title: Drug reaction with eosinophilia and systemic symptoms and severe involvement of digestive tract: description of two cases.
authors.forename: G
authors.initials: G
authors.lastname: Do-Pham
authors.forename: A
authors.initials: A
authors.lastname: Charachon
authors.forename: T A
authors.initials: TA
authors.lastname: Duong
authors.forename: A W
authors.initials: AW
authors.lastname: Thille
authors.forename: N
authors.initials: N
authors.lastname: Benhaiem
authors.forename: M
authors.initials: M
authors.lastname: Bagot
authors.forename: O
authors.initials: O
authors.lastname: Chosidow
authors.forename: J C
authors.initials: JC
authors.lastname: Roujeau
authors.forename: P
authors.initials: P
authors.lastname: Wolkenstein
authors.forename: L
authors.initials: L
authors.lastname: Valeyrie-Allanore
mesh_terms: D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D000927:Anticonvulsants / Q000009:adverse effects*; D018501:Antirheumatic Agents / Q000009:adverse effects*; D003093:Colitis, Ulcerative / Q000139:chemically induced* / Q000188:drug therapy; D003875:Drug Eruptions / Q000209:etiology*; D004802:Eosinophilia / Q000139:chemically induced*; D004941:Esophagitis / Q000139:chemically induced; D005260:Female; D006801:Humans; D007555:Isoxazoles / Q000009:adverse effects*; D000077213:Lamotrigine; D000077339:Leflunomide; D016896:Treatment Outcome; D014227:Triazines / Q000009:adverse effects*
chemical_list: D000305:Adrenal Cortex Hormones; D000927:Anticonvulsants; D018501:Antirheumatic Agents; D007555:Isoxazoles; D014227:Triazines; D000077339:Leflunomide; D000077213:Lamotrigine